March 1, 2021
Markets Insider
Idorsia submits NDA for clazosentan to Japanese PMDA
Allschwil, Switzerland - March 1, 2021Idorsia Ltd (SIX: IDIA) today announced the submission of a New... See more »
Accuronix Therapeutics
President & CEO
Dennis Schafer
Est. Annual Revenue
Est. Employees
Sector
Headquarters
ACCURONIX THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES
Missing a competitor? Contribute!
Jacobio Pharma is a top competitor of Accuronix Therapeutics. Jacobio Pharma was founded in Beijing, Beijing Municipality} in 2015. Jacobio Pharma competes in the Biotechnology industry. Compared to Accuronix Therapeutics, Jacobio Pharma generates $ less revenue.
Weigh-in!
Help the Owler community know moreTrending News for Accuronix Therapeutics and Accuronix Therapeutics's Competitors
March 1, 2021
MarketScreener
Arrowhead Pharmaceuticals : Files IND to Begin Phase 2b Study of ARO-APOC3 in Patients with Severe Hypertriglyceridemia
(marketscreener.com) Arrowhead Pharmaceuticals Inc. today announced that it has submitted an Investig... See more »
March 1, 2021
FinanzNachrichten
MorphoSys AG: Morphosys AG Preliminary Results for the Fiscal Year 2020 Exceeding Guidance
PLANEGG & MUNICH, GERMANY / ACCESSWIRE / March 01, 2021 / MorphoSys AG preliminary results for the fi... See more »
Accuronix Therapeutics Acquisitions
No recent acquisitions found related to Accuronix Therapeutics
Accuronix Therapeutics Funding History
Since Accuronix Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Accuronix Therapeutics has raised $625.0K. Accuronix Therapeutics' funding round was on Jan 2016 for a total of $625.0K
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Unattributed
Jan 2016
$625K
BioGenerator
Since Accuronix Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Accuronix Therapeutics has raised $625.0K. Accuronix Therapeutics' funding round was on Jan 2016 for a total of $625.0K
Accuronix Therapeutics Investments
No recent investments found related to Accuronix Therapeutics
Social Media
Accuronix Therapeutics Headquarters
20 South Sarah Street
St. Louis, Montana63108
Driving Directions »Trending Companies
IN THE NEWS
Texas Instruments | Linde | Adobe | Coop | Carter's | Costa | Pomerantzlawfirm | Marriott | TreeHouse | Taat Lifestyle | Vulcan Materials | Uber | Xiaomi | Vestmoldtransgaz | Huawei | OPPO | MyoKardia | Corning | Pantheon | Quidel | PBC | Akamai | Boeing | Thermo Fisher | Cedar | EOG Resources | Paychex | Remedy | POCO | Kirby McInerney | Scotiabank | Domino Printing | CSIM | Paytm | Merck | DIRECTV | Fastly | Quest Diagnostics | Seattle Genetics | Eli Lilly | United Rentals | Keysight | Malibu Boats | Dick's | YouTube | Sinovac | Ionis | Wausau Paper | Numotion | U.S. Bank
PEOPLE ALSO VIEWED
Midwestsanitizing | Synmr | Biotechnology Department Of Oread | Alen & Eveliza America Latina | Onemanshop | Sunstem | Azura Ophthalmics | BioSciConcepts | Cepmed | Team Organic | NanoSyrinx | Affinia Therapeutics | BioSpeciMan | Peptide Machines | The Research Network Limited | Cohn Lab - University Of Florida | Apollo Pharmaceuticals | Aldan Healthcare Pvt. Ltd | EuroBiotix | Tech Mais | Preserve Your Smile Dental | Blue Bell Orthodontics / Lower Merion Orthodontics David Markowitz Dmd | Vistapearldentalgroup | Optimumpt | Warringalprivate | COREx | Dale Christian School | Arun Electronics Ltd | Asq Projects | Soluciones del Hard
Accuronix Therapeutics Summary
ABOUT
Overview
Accuronix Therapeutics was founded in 2016. Accuronix Therapeutics' headquarters is located in St. Louis, Montana, USA 63108. It has raised 625.0K in 1 round. The latest round was in Jan 2016. Accuronix Therapeutics' primary investor is BioGenerator....
CEO
Accuronix Therapeutics's President & CEO, Dennis Schafer, currently has an approval rating of 80%. Accuronix Therapeutics's primary competitors are Jacobio Pharma, Roivant Sciences & Kymera.Website
accuronix.comFrequently Asked Questions about Accuronix Therapeutics
When was Accuronix Therapeutics founded?
Accuronix Therapeutics was founded in 2016Who is Accuronix Therapeutics's CEO?
Accuronix Therapeutics's CEO is Dennis SchaferHow much revenue does Accuronix Therapeutics generate?
Accuronix Therapeutics generates $2M in revenueHow much funding does Accuronix Therapeutics have?
Accuronix Therapeutics has historically raised $625K in funding
Where is Accuronix Therapeutics's headquarters?
Accuronix Therapeutics's headquarters is in St. Louis Montana, USAHow many employees does Accuronix Therapeutics have?
Accuronix Therapeutics has 10 employeesWhat sector does Accuronix Therapeutics operate in?
Accuronix Therapeutics is in PharmaceuticalsWho are Accuronix Therapeutics's competitors?
Accuronix Therapeutics's top competitors are Jacobio Pharma, Roivant Sciences, Kymera
